Early data reveals strong response rates in ovarian cancer cohort

New partnership aims to fast-track mRNA therapies from lab to clinic

First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex

Novel orexin receptor agonist shows potential to improve wakefulness

Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain

Trial explores regenerative macrophage therapy for liver disease

Deal covers biosimilars for gastroenterology, neurology and dermatology

Collaboration offers end-to-end support from donor sourcing to manufacturing

New subcutaneous autoinjector offers at-home treatment option for patients

MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma